Piper Sandler Maintains Neutral on Elanco Animal Health, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg has maintained a Neutral rating on Elanco Animal Health (NYSE:ELAN) and increased the price target from $11 to $12.
November 13, 2023 | 9:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has maintained a Neutral rating on Elanco Animal Health and raised the price target from $11 to $12.
The increase in price target by Piper Sandler could lead to a positive short term sentiment among investors, potentially causing a slight uptick in ELAN's stock price. However, since the rating remains Neutral, the impact may not be very significant.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100